Pediatrics · Saint Louis, MO
NPI
1194246769
Since 2017
Specialty
Pediatrics
Code 208000000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1 Childrens Pl
Saint Louis, MO, 63110
Phone (314) 454-6006
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,550
55 services
Medicare patients, 2024
14
Average age 47
Drug cost, 2024
$1.1M
25 prescriptions
Company payments, 2025
$26.53
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Ibrahim M Elsharkawi prescribed most often to Medicare patients was Ravicti (Glycerol Phenylbutyrate), with 12 prescriptions and refills. In total Ibrahim M Elsharkawi wrote 25 Medicare prescriptions that cost $1.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ravicti Glycerol Phenylbutyrate | 12 | 12 | Under 11 | $996K |
| Cystadane Betaine | 12 | 12 | Under 11 | $31K |
Brand drugs: 25 claims; generic drugs: 0 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ibrahim M Elsharkawi $26.53 ($26.53 in general payments such as food, travel and fees) from 1 company. The largest payer was Mirum Pharmaceuticals, Inc. with $26.53.
| Company | Payments | Amount |
|---|---|---|
| Mirum Pharmaceuticals, Inc. MIRM | 1 | $26.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.